Annual CFI
$0.00
+$6000.00+100.00%
31 December 2022
Summary:
Nymox Pharmaceutical annual cash flow from investing activities is currently $0.00, with the most recent change of +$6000.00 (+100.00%) on 31 December 2022. During the last 3 years, it has risen by +$13.00 thousand (+100.00%).NYMX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3000.00
-$3000.00-100.00%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly cash flow from investing activities is currently -$3000.00, with the most recent change of -$3000.00 (-100.00%) on 31 March 2023.NYMX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$3000.00
-$3000.00-100.00%
31 March 2023
Summary:
Nymox Pharmaceutical TTM cash flow from investing activities is currently -$3000.00, with the most recent change of -$3000.00 (-100.00%) on 31 March 2023.NYMX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +100.0% | -100.0% | +78.6% |
| 5 y5 years | +100.0% | -100.0% | +88.0% |
NYMX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -100.0% | -100.2% | -100.2% |
Nymox Pharmaceutical Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$3000.00(<-9900.0%) | -$3000.00(<-9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $0.00(0.0%) | -$4000.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | -$4000.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | -$4000.00(-33.3%) |
| Dec 2021 | -$6000.00(-53.8%) | -$4000.00(<-9900.0%) | -$6000.00(-57.1%) |
| Sept 2021 | - | $0.00(0.0%) | -$14.00 K(-6.7%) |
| June 2021 | - | $0.00(-100.0%) | -$15.00 K(0.0%) |
| Mar 2021 | - | -$2000.00(-83.3%) | -$15.00 K(+15.4%) |
| Dec 2020 | -$13.00 K(<-9900.0%) | -$12.00 K(+1100.0%) | -$13.00 K(+1200.0%) |
| Sept 2020 | - | -$1000.00(<-9900.0%) | -$1000.00(<-9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2019 | - | $0.00(-100.0%) | -$25.00 K(-30.6%) |
| Dec 2018 | -$36.00 K(<-9900.0%) | -$25.00 K(+127.3%) | -$36.00 K(+227.3%) |
| Sept 2018 | - | -$11.00 K(<-9900.0%) | -$11.00 K(+205.6%) |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Dec 2016 | -$2000.00(<-9900.0%) | - | - |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2014 | -$3500.00(-46.2%) | $0.00(-100.0%) | -$3600.00(-26.5%) |
| Sept 2014 | - | -$1500.00(<-9900.0%) | -$4900.00(-31.9%) |
| June 2014 | - | $0.00(-100.0%) | -$7200.00(0.0%) |
| Mar 2014 | - | -$2100.00(+61.5%) | -$7200.00(+10.8%) |
| Dec 2013 | -$6500.00(+91.2%) | -$1300.00(-65.8%) | -$6500.00(+25.0%) |
| Sept 2013 | - | -$3800.00(<-9900.0%) | -$5200.00(+52.9%) |
| June 2013 | - | $0.00(-100.0%) | -$3400.00(-10.5%) |
| Mar 2013 | - | -$1400.00(<-9900.0%) | -$3800.00(+11.8%) |
| Dec 2012 | -$3400.00(-84.6%) | $0.00(-100.0%) | -$3400.00(-41.4%) |
| Sept 2012 | - | -$2000.00(+400.0%) | -$5800.00(-3.3%) |
| June 2012 | - | -$400.00(-60.0%) | -$6000.00(-53.5%) |
| Mar 2012 | - | -$1000.00(-58.3%) | -$12.90 K(-41.9%) |
| Dec 2011 | -$22.10 K(+151.1%) | -$2400.00(+9.1%) | -$22.20 K(+7.8%) |
| Sept 2011 | - | -$2200.00(-69.9%) | -$20.60 K(+9.0%) |
| June 2011 | - | -$7300.00(-29.1%) | -$18.90 K(+50.0%) |
| Mar 2011 | - | -$10.30 K(+1187.5%) | -$12.60 K(+43.2%) |
| Dec 2010 | -$8800.00(+300.0%) | -$800.00(+60.0%) | -$8800.00(+10.0%) |
| Sept 2010 | - | -$500.00(-50.0%) | -$8000.00(-14.0%) |
| June 2010 | - | -$1000.00(-84.6%) | -$9300.00(+6.9%) |
| Mar 2010 | - | -$6500.00(<-9900.0%) | -$8700.00(+295.5%) |
| Dec 2009 | -$2200.00(-81.4%) | $0.00(-100.0%) | -$2200.00(-101.8%) |
| Sept 2009 | - | -$1800.00(+350.0%) | $125.10 K(+59.8%) |
| June 2009 | - | -$400.00(<-9900.0%) | $78.30 K(-763.6%) |
| Mar 2009 | - | $0.00(-100.0%) | -$11.80 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2008 | -$11.80 K(-99.0%) | $127.30 K(-361.9%) | -$11.80 K(-97.4%) |
| Sept 2008 | - | -$48.60 K(-46.3%) | -$461.20 K(-13.1%) |
| June 2008 | - | -$90.50 K(<-9900.0%) | -$530.80 K(-33.4%) |
| Mar 2008 | - | $0.00(-100.0%) | -$797.40 K(-32.9%) |
| Dec 2007 | -$1.19 M(+218.8%) | -$322.10 K(+172.5%) | -$1.19 M(+23.0%) |
| Sept 2007 | - | -$118.20 K(-66.9%) | -$966.80 K(+9.4%) |
| June 2007 | - | -$357.10 K(-8.8%) | -$883.60 K(+22.7%) |
| Mar 2007 | - | -$391.70 K(+292.5%) | -$719.90 K(+93.1%) |
| Dec 2006 | -$373.00 K(-34.1%) | -$99.80 K(+185.1%) | -$372.90 K(+24.8%) |
| Sept 2006 | - | -$35.00 K(-81.9%) | -$298.90 K(-2.6%) |
| June 2006 | - | -$193.40 K(+332.7%) | -$306.90 K(-35.4%) |
| Mar 2006 | - | -$44.70 K(+73.3%) | -$475.10 K(-16.0%) |
| Dec 2005 | -$565.80 K(+39.4%) | -$25.80 K(-40.0%) | -$565.80 K(+52.4%) |
| Sept 2005 | - | -$43.00 K(-88.1%) | -$371.20 K(-22.1%) |
| June 2005 | - | -$361.60 K(+167.1%) | -$476.70 K(+49.5%) |
| Mar 2005 | - | -$135.40 K(-180.2%) | -$318.90 K(-21.5%) |
| Dec 2004 | -$406.00 K(+37.7%) | $168.80 K(-213.7%) | -$406.00 K(-41.3%) |
| Sept 2004 | - | -$148.50 K(-27.1%) | -$691.70 K(+7.6%) |
| June 2004 | - | -$203.80 K(-8.4%) | -$642.60 K(+29.0%) |
| Mar 2004 | - | -$222.50 K(+90.3%) | -$498.30 K(+69.0%) |
| Dec 2003 | -$294.90 K(-26.0%) | -$116.90 K(+17.6%) | -$294.90 K(-6.2%) |
| Sept 2003 | - | -$99.40 K(+67.1%) | -$314.30 K(-12.3%) |
| June 2003 | - | -$59.50 K(+211.5%) | -$358.40 K(+12.1%) |
| Mar 2003 | - | -$19.10 K(-86.0%) | -$319.70 K(-19.8%) |
| Dec 2002 | -$398.50 K(+17.0%) | -$136.30 K(-5.0%) | -$398.50 K(+4.7%) |
| Sept 2002 | - | -$143.50 K(+589.9%) | -$380.60 K(+22.5%) |
| June 2002 | - | -$20.80 K(-78.8%) | -$310.60 K(-19.1%) |
| Mar 2002 | - | -$97.90 K(-17.3%) | -$384.10 K(+12.7%) |
| Dec 2001 | -$340.70 K(+10.4%) | -$118.40 K(+61.1%) | -$340.70 K(+28.1%) |
| Sept 2001 | - | -$73.50 K(-22.1%) | -$266.00 K(-9.0%) |
| June 2001 | - | -$94.30 K(+73.0%) | -$292.20 K(-4.5%) |
| Mar 2001 | - | -$54.50 K(+24.7%) | -$306.10 K(-0.8%) |
| Dec 2000 | -$308.60 K(-120.8%) | -$43.70 K(-56.2%) | -$308.60 K(-127.5%) |
| Sept 2000 | - | -$99.70 K(-7.9%) | $1.12 M(-0.1%) |
| June 2000 | - | -$108.20 K(+89.8%) | $1.12 M(-21.5%) |
| Mar 2000 | - | -$57.00 K(-104.1%) | $1.43 M(-3.8%) |
| Dec 1999 | $1.49 M(-292.3%) | $1.39 M(-1498.4%) | $1.49 M(-414.7%) |
| Sept 1999 | - | -$99.10 K(-149.8%) | -$472.10 K(+26.4%) |
| June 1999 | - | $199.00 K(>+9900.0%) | -$373.40 K(-44.5%) |
| Mar 1999 | - | $0.00(-100.0%) | -$672.60 K(-12.9%) |
| Dec 1998 | -$772.50 K(+286.6%) | -$572.00 K(>+9900.0%) | -$772.50 K(+285.3%) |
| Sept 1998 | - | -$400.00(-99.6%) | -$200.50 K(+0.2%) |
| June 1998 | - | -$100.20 K(+0.3%) | -$200.10 K(+100.3%) |
| Mar 1998 | - | -$99.90 K | -$99.90 K |
| Dec 1997 | -$199.80 K | - | - |
FAQ
- What is Nymox Pharmaceutical annual cash flow from investing activities?
- What is the all time high annual CFI for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical TTM cash flow from investing activities?
- What is the all time high TTM CFI for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual cash flow from investing activities?
The current annual CFI of NYMX is $0.00
What is the all time high annual CFI for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual cash flow from investing activities is $1.49 M
What is Nymox Pharmaceutical quarterly cash flow from investing activities?
The current quarterly CFI of NYMX is -$3000.00
What is the all time high quarterly CFI for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly cash flow from investing activities is $1.39 M
What is Nymox Pharmaceutical TTM cash flow from investing activities?
The current TTM CFI of NYMX is -$3000.00
What is the all time high TTM CFI for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high TTM cash flow from investing activities is $1.49 M